Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activation.
J Pharmacol Exp Ther
; 352(2): 315-24, 2015 Feb.
Article
in En
| MEDLINE
| ID: mdl-25472953
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Inflammatory Bowel Diseases
/
Receptors, Steroid
/
Colon
/
Ginsenosides
/
Anti-Inflammatory Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
J Pharmacol Exp Ther
Year:
2015
Type:
Article